Cervini L A, Gray W R, Kaiser R, Dykert J, Chan R, Solomon S, Rivier C L, Rivier J E
Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, CA 92186-5800, USA.
Peptides. 1995;16(5):837-42. doi: 10.1016/0196-9781(95)00040-q.
We have synthesized significant amounts of the most potent member of the rat corticostatins that inhibits ACTH-induced corticosteroid and compared its structure to that of the natural hormone. The cystine bridging arrangement that corresponds to that reported for a human defensin (3-31, 5-20, 10-30) was determined. The in vitro corticostatic activity of the synthetic rat corticostatin R4 paralleled that of the natural R4. Biological studies in vivo showed that doses of 8 or 12 mg corticostatin/kg effectively interfered with corticosterone release in stressed rats. We conclude that in the assays that were used, the biological activity of the synthetic and natural molecules was identical. The availability of significant amounts of synthetic material will make possible studies investigating the physiological role played by corticostatins in modulating the activity of the hypothalamic-pituitary-adrenal axis.
我们已经合成了大量大鼠皮质抑制素中最具活性的成员,该成员可抑制促肾上腺皮质激素诱导的皮质类固醇,并将其结构与天然激素的结构进行了比较。确定了与人类防御素(3-31、5-20、10-30)报道的结构相对应的胱氨酸桥接排列方式。合成的大鼠皮质抑制素R4的体外皮质抑制活性与天然R4的活性相当。体内生物学研究表明,皮质抑制素剂量为8或12 mg/kg时可有效干扰应激大鼠体内皮质酮的释放。我们得出结论,在所使用的测定中,合成分子和天然分子的生物活性是相同的。大量合成材料的可得性将使研究皮质抑制素在调节下丘脑-垂体-肾上腺轴活性中所起的生理作用成为可能。